Genmab Shares Jump on Rina-S Ovarian Cancer Data Genmab Shares Jump as Rina-S Shows Durable Ovarian Cancer Responses in Phase 2 Trial Genmab shares jumped more than 4% on Monday after the... October 05, 2026 Read Guide →
